DELTEX

Welcome to the Brand page for “DELTEX”, which is offered here for Pharmaceuticals in the nature of cell therapeutics for the treatment and prevention of cancer; engineered cell therapies, engineered t cells, immune cells, and antibodies for the treatment and prevention of cancer;medical services; providing health information; providing health information in the field of bioengineering and genetic engineering; providing health information in the field of autoimmune, inflammatory and infectious diseases and disorders, cancer prevention and treatment; medical diagnosis and treatment of cancer, autoimmune, inflammatory, and infectious diseases and disorders;medical research and development; research and development of pharmaceuticals; research and development in the field of bioengineering and genetic engineering; research and development of treatments and therapies in the field of oncology; research and development of pharmaceuticals for the treatment and prevention of cancer, autoimmune, inflammatory, and infectious diseases and disorders; scientific research for medical purposes in the field of cancer, autoimmune, inflammatory, and infectious diseases and disorders; molecular, cellular, and genetic research and development; development of processes and methods for the manufacturing and engineering of cells and molecules; development of therapeutics and treatments for the prevention of cancer, autoimmune, inflammatory, genetic and infectious diseases and disorders;.

Its status is currently believed to be active. Its class is unavailable. “DELTEX” is believed to be currently owned by “IN8BIO, INC.”